Triopil 1 Tablet 10

Triopil 1 Tablet is used in adults to manage type 2 diabetes, helping to control blood sugar and reduce the risk of long-term complications.

Uses of Triopil 1 Tablet are:

• Type 2 Diabetes: Helps control high blood sugar levels.
• Steadier Control: Uses medicines that work in different ways for steadier blood sugar.
• Complication Risk: Helps reduce the risk of long-term diabetes-related problems.

• Swallow the whole tablet with a meal to minimise gastrointestinal side effects.

• Avoid crushing, chewing, or dividing the tablet.

• Do not exceed the recommended dose without consulting your doctor.

• It's essential not to stop taking this medicine without speaking to your doctor first.

Triopil 1 Tablet 10 is taken orally.

Okamet Gmp 1 combines three active ingredients:

• Glimepiride (1 mg): This component acts on specific receptors present in the pancreas. It triggers a series of actions which result in insulin being released from the pancreas. Insulin is a hormone that helps regulate blood sugar levels.

• Metformin (500 mg): This works by reducing the amount of glucose produced by the liver. It also improves insulin sensitivity which leads to better absorption and utilisation of glucose by the body's cells.

• Pioglitazone (15 mg): This ingredient targets receptor sites found in fat and muscle cells. By activating these receptors, pioglitazone enhances these cells' sensitivity to insulin, leading to improved blood sugar regulation.

• Store Triopil 1 Tablet 10 in a cool, dry place at a temperature below 30°C.

• Avoid exposing the product to light and moisture.

• Always keep the tablet out of reach of children.

• To manage blood glucose levels better, eat a balanced diet rich in fibre and low in simple sugars, including whole grains, fruits, vegetables, and lean proteins.

• Regular physical activity, such as walking, cycling, or yoga, can help improve insulin sensitivity and maintain optimal blood glucose levels. Remember to consult your doctor before starting any new exercise routine.